Table of Content

1 Market Overview
1.1 OTC Drug Introduction
1.2 Market Analysis by Types
1.3 Market Analysis by Applications
1.4 Global OTC Drug Market Size & Forecast
1.4.1 Global OTC Drug Revenue (2018 VS 2022 VS 2029)
1.4.2 Global OTC Drug Revenue in Value (2018-2029)
1.5 Market Drivers, Restraints and Trends
1.5.1 OTC Drug Market Drivers
1.5.2 OTC Drug Market Restraints
1.5.3 OTC Drug Trends Analysis
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Manufacturers Profiles
2.1 Bayer HealthCare
2.1.1 Business Overview
2.1.2 Bayer HealthCare SWOT Analysis
2.1.3 Bayer HealthCare OTC Drug Products and Service Offered
2.1.4 Bayer HealthCare OTC Drug Revenue and Gross Margin
2.2 GlaxoSmithKline(GSK)
2.2.1 Business Overview
2.2.2 GlaxoSmithKline(GSK) SWOT Analysis
2.2.3 GlaxoSmithKline(GSK) OTC Drug Products and Service Offered
2.2.4 GlaxoSmithKline(GSK) OTC Drug Revenue and Gross Margin
2.3 Johnson&Johnson
2.3.1 Business Overview
2.3.2 Johnson&Johnson SWOT Analysis
2.3.3 Johnson&Johnson OTC Drug Products and Service Offered
2.3.4 Johnson&Johnson OTC Drug Revenue and Gross Margin
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Pfizer SWOT Analysis
2.4.3 Pfizer OTC Drug Products and Service Offered
2.4.4 Pfizer OTC Drug Revenue and Gross Margin
2.5 Sanofi
2.5.1 Business Overview
2.5.2 Sanofi SWOT Analysis
2.5.3 Sanofi OTC Drug Products and Service Offered
2.5.4 Sanofi OTC Drug Revenue and Gross Margin
2.6 AstraZeneca
2.6.1 Business Overview
2.6.2 AstraZeneca SWOT Analysis
2.6.3 AstraZeneca OTC Drug Products and Service Offered
2.6.4 AstraZeneca OTC Drug Revenue and Gross Margin
2.7 BioGaia
2.7.1 Business Overview
2.7.2 BioGaia SWOT Analysis
2.7.3 BioGaia OTC Drug Products and Service Offered
2.7.4 BioGaia OTC Drug Revenue and Gross Margin
2.8 Bristol Myers Squibb
2.8.1 Business Overview
2.8.2 Bristol Myers Squibb SWOT Analysis
2.8.3 Bristol Myers Squibb OTC Drug Products and Service Offered
2.8.4 Bristol Myers Squibb OTC Drug Revenue and Gross Margin
2.9 Bukwang Pharmaceutica
2.9.1 Business Overview
2.9.2 Bukwang Pharmaceutica SWOT Analysis
2.9.3 Bukwang Pharmaceutica OTC Drug Products and Service Offered
2.9.4 Bukwang Pharmaceutica OTC Drug Revenue and Gross Margin
2.10 Chr. Hansen
2.10.1 Business Overview
2.10.2 Chr. Hansen SWOT Analysis
2.10.3 Chr. Hansen OTC Drug Products and Service Offered
2.10.4 Chr. Hansen OTC Drug Revenue and Gross Margin
2.11 Cipla
2.11.1 Business Overview
2.11.2 Cipla SWOT Analysis
2.11.3 Cipla OTC Drug Products and Service Offered
2.11.4 Cipla OTC Drug Revenue and Gross Margin
2.12 CoLucid
2.12.1 Business Overview
2.12.2 CoLucid SWOT Analysis
2.12.3 CoLucid OTC Drug Products and Service Offered
2.12.4 CoLucid OTC Drug Revenue and Gross Margin
2.13 Daiichi Sankyo
2.13.1 Business Overview
2.13.2 Daiichi Sankyo SWOT Analysis
2.13.3 Daiichi Sankyo OTC Drug Products and Service Offered
2.13.4 Daiichi Sankyo OTC Drug Revenue and Gross Margin
2.14 Friggs
2.14.1 Business Overview
2.14.2 Friggs SWOT Analysis
2.14.3 Friggs OTC Drug Products and Service Offered
2.14.4 Friggs OTC Drug Revenue and Gross Margin
2.15 DSM
2.15.1 Business Overview
2.15.2 DSM SWOT Analysis
2.15.3 DSM OTC Drug Products and Service Offered
2.15.4 DSM OTC Drug Revenue and Gross Margin
2.16 Eisai
2.16.1 Business Overview
2.16.2 Eisai SWOT Analysis
2.16.3 Eisai OTC Drug Products and Service Offered
2.16.4 Eisai OTC Drug Revenue and Gross Margin
2.17 Eli Lilly
2.17.1 Business Overview
2.17.2 Eli Lilly SWOT Analysis
2.17.3 Eli Lilly OTC Drug Products and Service Offered
2.17.4 Eli Lilly OTC Drug Revenue and Gross Margin
2.18 Herbalife
2.18.1 Business Overview
2.18.2 Herbalife SWOT Analysis
2.18.3 Herbalife OTC Drug Products and Service Offered
2.18.4 Herbalife OTC Drug Revenue and Gross Margin
2.19 Euradite
2.19.1 Business Overview
2.19.2 Euradite SWOT Analysis
2.19.3 Euradite OTC Drug Products and Service Offered
2.19.4 Euradite OTC Drug Revenue and Gross Margin
3 Global OTC Drug Market Competition, by Manufacturer
3.1 Global OTC Drug Revenue and Market Share by Manufacturer
3.2 Market Concentration Rate
3.2.1 Top 3 OTC Drug Players Market Share in 2022
3.2.2 Top 6 OTC Drug Players Market Share in 2022
3.2.3 Market Competition Trend
3.3 OTC Drug Players Head Office, Business Provided
3.4 OTC Drug Mergers & Acquisitions
3.5 OTC Drug New Entrants and Expansion Plans
4 Market Segment by Type
4.1 Global OTC Drug Revenue in Value by Type (2018-2029)
4.2 Global OTC Drug Revenue Share by Type (2018-2029)
5 Market Segment by Application
5.1 Global OTC Drug Revenue by Application (2018-2029)
5.2 Global OTC Drug Revenue Share by Application (2018-2029)
6 Global OTC Drug Market Analysis by Regions
6.1 Global OTC Drug Revenue and Market Share by Regions
6.1.1 Global OTC Drug Revenue by Regions (2018-2029)
6.1.2 Global OTC Drug Revenue Market Share by Regions (2018-2029)
6.2 North America OTC Drug Revenue and Growth (2018-2029)
6.3 Europe OTC Drug Revenue and Growth (2018-2029)
6.4 Asia Pacific OTC Drug Revenue and Growth (2018-2029)
6.5 South America OTC Drug Revenue and Growth (2018-2029)
6.6 Middle East and Africa OTC Drug Revenue and Growth (2018-2029)
7 North America OTC Drug by Country, by Type, and by Application
7.1 North America OTC Drug Revenue by Type (2018-2029)
7.2 North America OTC Drug Revenue by Application (2018-2029)
7.3 North America OTC Drug Revenue and Market Share by Countries
7.3.1 North America OTC Drug Revenue in Value by Country (2018-2029)
7.3.2 United States OTC Drug Revenue and Growth (2018-2029)
7.3.3 Canada OTC Drug Revenue and Growth (2018-2029)
7.3.4 Mexico OTC Drug Revenue and Growth (2018-2029)
7.4 North America SWOT Analysis
8 Europe OTC Drug by Country, by Type, and by Application
8.1 Europe OTC Drug Revenue by Type (2018-2029)
8.2 Europe OTC Drug Revenue by Application (2018-2029)
8.3 Europe OTC Drug Revenue and Market Share by Countries
8.3.1 Europe OTC Drug Revenue in Value by Country (2018-2029)
8.3.2 Germany OTC Drug Revenue and Growth (2018-2029)
8.3.3 France OTC Drug Revenue and Growth (2018-2029)
8.3.4 United Kingdom OTC Drug Revenue and Growth (2018-2029)
8.3.5 Russia OTC Drug Revenue and Growth (2018-2029)
8.3.6 Italy OTC Drug Revenue and Growth (2018-2029)
8.3.7 Nordic OTC Drug Revenue and Growth (2018-2029)
8.4 Europe SWOT Analysis
9 Asia Pacific OTC Drug by Country, by Type, and by Application
9.1 Asia Pacific OTC Drug Revenue by Type (2018-2029)
9.2 Asia Pacific OTC Drug Revenue by Application (2018-2029)
9.3 Asia Pacific OTC Drug Revenue and Market Share by Countries
9.3.1 Asia Pacific OTC Drug Revenue in Value by Country (2018-2029)
9.3.2 China OTC Drug Revenue and Growth (2018-2029)
9.3.3 Japan OTC Drug Revenue and Growth (2018-2029)
9.3.4 Korea OTC Drug Revenue and Growth (2018-2029)
9.3.5 India OTC Drug Revenue and Growth (2018-2029)
9.3.6 Southeast Asia OTC Drug Revenue and Growth (2018-2029)
9.3.7 Australia OTC Drug Revenue and Growth (2018-2029)
9.4 Asia Pacific SWOT Analysis
10 South America OTC Drug by Country, by Type, and by Application
10.1 South America OTC Drug Revenue by Type (2018-2029)
10.2 South America OTC Drug Revenue by Application (2018-2029)
10.3 South America OTC Drug Revenue and Market Share by Countries
10.3.1 South America OTC Drug Revenue in Value by Country (2018-2029)
10.3.2 Brazil OTC Drug Revenue and Growth (2018-2029)
10.3.3 Argentina OTC Drug Revenue and Growth (2018-2029)
10.4 South America SWOT Analysis
11 Middle East & Africa OTC Drug by Country, by Type, and by Application
11.1 Middle East & Africa OTC Drug Revenue by Type (2018-2029)
11.2 Middle East & Africa OTC Drug Revenue by Application (2018-2029)
11.3 Middle East & Africa OTC Drug Revenue and Market Share by Countries
11.3.1 Middle East & Africa OTC Drug Revenue in Value by Country (2018-2029)
11.3.2 Turkey OTC Drug Revenue and Growth (2018-2029)
11.3.3 Egypt OTC Drug Revenue and Growth (2018-2029)
11.3.4 Saudi Arabia OTC Drug Revenue and Growth (2018-2029)
11.3.5 UAE OTC Drug Revenue and Growth (2018-2029)
11.3.6 South Africa OTC Drug Revenue and Growth (2018-2029)
11.4 Middle East and Africa SWOT Analysis
12 OTC Drug Business Cost Analysis
12.1 Proportion of Business Cost Structure
12.1.1 Labor Cost
12.1.2 Operating Expenses
12.2 OTC Drug Industrial Chain Analysis
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 A Methodology
14.1.1 Research Process
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 B Data Source
14.2.1 Legal Disclaimer